MALIGNANT TUMOR
Clinical trials for MALIGNANT TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine aims to train immune system against Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new type of cancer vaccine made from a person's own tumor cells. The goal is to see if it is safe and can help control advanced solid tumors like bone, pancreatic, or liver cancer. About 54 people with different cancers will receive the vaccine, and…
Matched conditions: MALIGNANT TUMOR
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 26, 2026 03:50 UTC
-
New alpha radiation therapy offers hope for Hard-to-Treat tumors
Disease control Recruiting nowThis study is testing a new type of radiation therapy called DaRT for people with malignant tumors. The goal is to see how safe it is and whether it can shrink tumors. About 100 adults with tumors up to 7 cm will receive the treatment and be monitored for side effects and tumor r…
Matched conditions: MALIGNANT TUMOR
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope for advanced cancers: JAB-8263 enters human testing
Disease control Recruiting nowThis study tests a new drug called JAB-8263 in adults with advanced solid tumors or blood cancers that have stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors. About 152 people will take part in this early-phase tr…
Matched conditions: MALIGNANT TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New imaging scan could spot hidden diseases earlier
Diagnosis Recruiting nowThis study is testing a new type of PET scan that uses a special tracer to take clearer pictures of cancers, heart problems, and immune diseases. Researchers will check how safe the tracer is and how well it finds disease compared to standard methods. About 600 adults will take p…
Matched conditions: MALIGNANT TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated May 26, 2026 03:53 UTC
-
New scan could spot hidden cancers
Diagnosis Recruiting nowThis study is testing a new radioactive tracer that attaches to a protein called EphA2, which is found in high amounts on many solid tumors. The goal is to see if this tracer can make tumors show up more clearly on PET scans. About 30 adults with suspected or confirmed cancer wil…
Matched conditions: MALIGNANT TUMOR
Sponsor: First Hospital of China Medical University • Aim: Diagnosis
Last updated May 20, 2026 11:54 UTC
-
Can Pre-Treatment rehab boost cancer outcomes?
Symptom relief Recruiting nowThis study tests whether a tailored exercise and support program before cancer treatment helps adults with cancer feel better and function better. About 60 people referred to UNC will be randomly assigned to the program or usual care. The goal is to see if this approach improves …
Matched conditions: MALIGNANT TUMOR
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 04:06 UTC
-
Mind over malignancy: 2,000-Patient study probes Distress-Disease link
Knowledge-focused Recruiting nowThis study follows 2,000 adults with various cancers to see if psychological distress (like anxiety or depression) impacts how well they stick to treatment, their health outcomes, and their quality of life. Participants complete questionnaires and are tracked for 3 years. The goa…
Matched conditions: MALIGNANT TUMOR
Sponsor: Gang Chen, MD • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC
-
New study tests whether a 'Research Navigator' boosts cancer trial enrollment
Knowledge-focused Recruiting nowThis study looks at whether adding a special helper called an oncology research navigator (ORN) to standard cancer care helps patients learn about and join clinical trials and support services. About 686 adults with new cancer appointments at UNC Medical Center will take part. Th…
Matched conditions: MALIGNANT TUMOR
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC